Alexoudi, V.-A.; Gavriilaki, E.; Cheva, A.; Sakellari, I.; Papadopoulou, S.; Paraskevopoulos, K.; Vahtsevanos, K.
Graft-Versus-Host Disease: Can Biomarkers Assist in Differential Diagnosis, Prognosis, and Therapeutic Strategy? Pharmaceuticals 2024, 17, 298.
https://doi.org/10.3390/ph17030298
AMA Style
Alexoudi V-A, Gavriilaki E, Cheva A, Sakellari I, Papadopoulou S, Paraskevopoulos K, Vahtsevanos K.
Graft-Versus-Host Disease: Can Biomarkers Assist in Differential Diagnosis, Prognosis, and Therapeutic Strategy? Pharmaceuticals. 2024; 17(3):298.
https://doi.org/10.3390/ph17030298
Chicago/Turabian Style
Alexoudi, Vaia-Aikaterini, Eleni Gavriilaki, Angeliki Cheva, Ioanna Sakellari, Stavroula Papadopoulou, Konstantinos Paraskevopoulos, and Konstantinos Vahtsevanos.
2024. "Graft-Versus-Host Disease: Can Biomarkers Assist in Differential Diagnosis, Prognosis, and Therapeutic Strategy?" Pharmaceuticals 17, no. 3: 298.
https://doi.org/10.3390/ph17030298
APA Style
Alexoudi, V.-A., Gavriilaki, E., Cheva, A., Sakellari, I., Papadopoulou, S., Paraskevopoulos, K., & Vahtsevanos, K.
(2024). Graft-Versus-Host Disease: Can Biomarkers Assist in Differential Diagnosis, Prognosis, and Therapeutic Strategy? Pharmaceuticals, 17(3), 298.
https://doi.org/10.3390/ph17030298
